Xiaofei Wang
7Patents
3h-index
28Co-inventors
53Inventor score
Filing activity: Dec 16, 2004 → Nov 2, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9938301B2 | Dihydropyrimido fused ring derivative as HBV inhibitor | Chemistry; Metallurgy | 26 | Active |
| US10253030B2 | Crystal form, preparation method and intermediate of dihydropyrido ring compound | Chemistry; Metallurgy | 24 | Active |
| US9687539B2 | CD4+ T survivin epitopes and uses thereof | Human Necessities | 3 | Active |
| US11117899B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | Human Necessities | 2 | Active |
| US11066411B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | General | 0 | Revoked |
| US11377444B2 | Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7666590B2 | Identification of fat and lean phenotypes in chickens using molecular markers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.